Keywords: strong, performace, shire, uk-based, pharmaceuticals, says, another
Strong performace for Shire in 2003
Article | 22 March 2004
UK-based Shire Pharmaceuticals says it had "another excellent year in 2003," reporting revenues up 19% at $1.24 billion. These were largely made up ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
